Broadening Primary Aldosteronism Screening: Alignment Across Contemporary Guidelines

原发性醛固酮增多症 医学 指南 血压 重症监护医学 继发性高血压 疾病 流行病学 肾脏疾病 醛固酮增多症 内科学 不利影响 梅德林 儿科 临床实习 内分泌系统 原发性高血压 生物信息学 电子健康档案 肾 抵抗性高血压 金标准(测试) 醛固酮 疾病负担
作者
Lily Owei,Heather Wachtel,Jordana B. Cohen
出处
期刊:Hypertension [Lippincott Williams & Wilkins]
卷期号:83 (5): e26228-e26228 被引量:9
标识
DOI:10.1161/hypertensionaha.125.26228
摘要

Fewer than 2% of eligible patients are screened for primary aldosteronism, despite evidence that early detection and targeted therapy are associated with lower cardiovascular and kidney morbidity. Recent updates to major hypertension and endocrine guidelines reflect growing recognition that primary aldosteronism is far more prevalent than previously understood and that broader, more practical screening approaches are needed. These recommendations increasingly extend screening beyond resistant hypertension to adults with stage 2 hypertension and even to all individuals with hypertension. They also aim to lower barriers to testing through more flexible guidance on antihypertensive medication management, reaffirm the aldosterone-to-renin ratio as the preferred initial test, and provide more standardized criteria for interpretation. Supporting evidence includes epidemiological data demonstrating a continuum of renin-independent aldosterone production across blood pressure categories, strong associations between untreated primary aldosteronism and adverse cardiovascular and kidney outcomes independent of blood pressure, and favorable cost-effectiveness of screening even in lower-risk groups. Implementation remains the principal challenge, with obstacles spanning patient, clinician, and health system levels. Emerging electronic health record strategies, including electronic phenotyping and integrated clinical decision support, have shown early promise in increasing screening uptake and streamlining diagnostic pathways. Collectively, contemporary guideline updates and implementation innovations represent a shift toward earlier and broader detection of primary aldosteronism, with the potential to reduce preventable cardiorenal disease across the hypertensive population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
霞霞子完成签到 ,获得积分10
1秒前
NexusExplorer的应助被霖29采纳,获得10
2秒前
星火完成签到,获得积分10
2秒前
嘻嘻哈哈的应助被IceCup采纳,获得10
2秒前
李可心完成签到,获得积分10
2秒前
大模型的应助被聪慧雪糕采纳,获得10
3秒前
彼岸发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
和谐雪曼发布了新的文献求助10
4秒前
466完成签到,获得积分10
5秒前
5秒前
5秒前
guo完成签到,获得积分10
5秒前
科研菜菜的应助被科研通管家采纳,获得30
5秒前
5秒前
汉堡包的应助被科研通管家采纳,获得10
5秒前
5秒前
6秒前
英姑的应助被科研通管家采纳,获得10
6秒前
打打的应助被科研通管家采纳,获得10
6秒前
ef完成签到,获得积分10
6秒前
汉堡包的应助被科研通管家采纳,获得10
6秒前
乐乐的应助被科研通管家采纳,获得10
6秒前
慕青的应助被科研通管家采纳,获得10
6秒前
6秒前
null的应助被科研通管家采纳,获得10
6秒前
6秒前
可恶地发布了新的文献求助10
6秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
6秒前
DW的应助被科研通管家采纳,获得10
7秒前
传奇3的应助被科研通管家采纳,获得10
7秒前
秋风的应助被科研通管家采纳,获得20
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
7秒前
7秒前
7秒前
Hello的应助被科研通管家采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183694
求助须知:如何正确求助?哪些是违规求助? 9572963
关于积分的说明 21828306
捐赠科研通 7780864
什么是DOI,文献DOI怎么找? 3434057
关于科研通互助平台的介绍 2558257
邀请新用户注册赠送积分活动 2480541